Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03909386
Other study ID # K21
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 26, 2019
Est. completion date September 30, 2022

Study information

Verified date January 2023
Source Heart Care Foundation
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

AF and cancer frequently coexist. Since these patients are usually excluded from randomized trials, information on their management and outcome is scarce. Occurrence of relevant clinical events, such as ischemic and hemorrhagic and all-cause mortality and cardiovascular (CV) mortality occurring in patients treated or not with antithrombotic agents needs to be clarified. A prospective observational registry collecting information, in a real world setting, on the clinical profile of patients with these clinical conditions and on the use of antithrombotic drugs in patients with AF and cancer could improve our knowledge on the management of these high risk patients.


Description:

International, multicenter, non-interventional study on patients with atrial fibrillation (AF) and cancer (diagnosed within the last 3 years prior to enrolment). The study will be conducted in about 80 sites in italy and 50 sites distributed in other European countries (Belgium, Germany, Ireland, Portugal, Spain, The Netherlands, Turkey). The study will continue till the consecutive recruitment of 1500 patients. The recruitment period will last approximately 24 months. Number of visits per patient: Baseline and 1 year (Final). Physicians will not be required to perform any additional tests, assessments, etc., not in line with their routine medical practice.


Recruitment information / eligibility

Status Completed
Enrollment 1514
Est. completion date September 30, 2022
Est. primary completion date September 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Both sexes - Age >18 years - Patient with diagnosed AF (any type of AF, electrocardiographically documented within 1 year prior to enrolment) - Patient with a documented cancer (diagnosed within the last 3 years prior to enrolment into this registry), including melanoma but not other basal-cell or squamous-cell carcinoma of the skin. The diagnosis/history of cancer must be objectively documented. - Written informed consent (IC) for participation in the study - Patient not simultaneously participating in any interventional study. Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Belgium OLV ZIEKENHUIS AALST - Cardiology Aalst
Belgium AZ IMELDA - Cardiology Bonheiden
Belgium AZ ST-JAN - Cardiology Brugge
Belgium UZ Brussel - Cardiology Brussel
Belgium Hôpital Erasme - Cardiology Brussels
Belgium UCL Cliniques universitaires Saint-Luc - Cardiolgy Brussels
Belgium Ziekenhuis Oost-Limburg - Cardiology Genk
Belgium JESSA HASSELT - Cardiology Hasselt
Belgium AZ GROENINGE - Cardiology Kortrijk
Belgium UZ LEUVEN - Cardiovascular diseases Leuven
Belgium AZ DELTA ROESELARE - Cardiology Roeselare
Belgium AZ TURNHOUT - Cardiology Turnhout
Ireland Bon Secours Hospital Cork - Oncology Department Cork
Ireland Beacon Hospital, Cardiology Dublin
Ireland Tallaght University Hospital - Geriatric and Stroke Medicine Department Dublin
Italy Ospedale Miulli - U.O.C. Cardiologia - Utic Acquaviva Delle Fonti
Italy Ospedale San Giovanni Di Dio - Uo Cardiologia E Utic Agrigento AG
Italy Ospedale Ss. Vito E Spirito - U.O.S. Di Cardiologia Alcamo TP
Italy Ospedale San Donato - U.O. Cardiologia Arezzo AR
Italy Nuovo Ospedale Dei Castelli - U.O.C. Di Cardiologia E Utic Ariccia RM
Italy Ospedale Civile - U.O.C. Cardiologia Arzignano VI
Italy Ospedale E. Muscatello - U.O. Di Cardiologia - Utic Augusta SR
Italy Centro Di Riferimento Oncologico (Cro) - Cardiologia Aviano PN
Italy Istituto Tumori Giovanni Paolo Ii - U.O. Di Cardiologia Bari BA
Italy Ospedale San Paolo - Cardiologia-Utic Bari BA
Italy Ospedale Civile - Sc Cardiologia Belluno BL
Italy Ospedale Bellaria - U.O. Di Cardiologia Bologna BO
Italy Ospedale Maggiore - U.O. Di Cardiologia Bologna BO
Italy Ospedale Policlinico S. Orsola-Malpighi - U.O. Cardiologia-Rapezzi Bologna BO
Italy Ospedale Ss. Trinita' - S.C. Di Cardiologia Borgomanero
Italy Ospedale A. Businco - Servizio Di Cardiologia Cagliari CA
Italy Ospedale Roberto Binaghi - Servizio Di Cardiologia Cagliari CA
Italy Ospedale Barone Lombardo - Cardiologia E Utic Canicattì AG
Italy Ospedale Ramazzini - U.O. Cardiologia Carpi MO
Italy Ospedale Santo Spirito - Sc Cardiologia Casale Monferrato AL
Italy Az. Ospedaliera S. Anna E S. Sebastiano - Cardiologia Clinica Universitaria - Utic Caserta CE
Italy Az. Ospedaliera S. Anna E S. Sebastiano - Uoc Medicina E Chirurgia D'Urgenza Caserta
Italy Ospedale Di Castellaneta - S.C. Cardiologia Castellaneta TA
Italy Ospedale Civile Ferrari - U.O.C. Cardiologia-Utic Castrovillari CS
Italy Azienda Ospedaliera Cannizzaro - Uoc Cardiologia Con Utic Ed Emodinamica Catania CT
Italy Humanitas Centro Catanese Di Oncologia - Servizio Di Cardiologia Catania CT
Italy P.O. Garibaldi-Nesima - U.O.C. Di Cardiologia Catania CT
Italy Fondazione G. Giglio - U.O. Cardiologia E Utic Cefalù PA
Italy Ospedale Policlinico Ss. Annunziata - Medicina Generale Ii Chieti
Italy Ospedale San Giuseppe Da Copertino - U.O. Di Cardiologia-Utic Copertino LE
Italy Ospedale Civile San Giuseppe - Cardiologia Empoli FI
Italy Ospedale Civile Profili - U.O. Cardiologia Fabriano AN
Italy Ospedale Santa Maria Del Prato - U.O. Di Cardiologia Feltre BL
Italy Arcispedale Sant'Anna - U.O. Cardiologia - Utic Ferrara
Italy Aou Careggi - Cardiologa Diagnostica Firenze FI
Italy Aou Careggi - Diagnostica Cardiovascolare Firenze FI
Italy Ospedale San Giovanni Di Dio - Cardiologia Firenze FI
Italy Ospedali Riuniti - S.C. Di Cardiologia Univ.-Utic Foggia FG
Italy Ospedale Padre Antero Micone - Sc Cardiologia - Utic Genova GE
Italy Ospedale Policlinico San Martino - Clinica Malattie Cardiovascolari Genova GE
Italy Ospedale Generale Di Zona - U.O. Cardiologia - Utic Giugliano In Campania
Italy Ospedale Civile - Sc Cardiologia Area Nord Guastalla RE
Italy Nuovo Ospedale Versilia - Sc Cardiologia Lido Di Camaiore LU
Italy Ospedale Civile M. Giannuzzi - Cardiologia E Utic Manduria TA
Italy Presidio Ospedaliero Della Valle D'Itria - Struttura Complessa Di Cardiologia Martina Franca TA
Italy Policlinico G. Martino - U.O. Medicina Interna Messina ME
Italy Asst Ospedale Metropolitano Niguarda - Cardiologia 4 -Diagnost. E Riabilitativa Milano MI
Italy Istituto Europeo Di Oncologia - Cardiologia Milano MI
Italy Istituto Nazionale Tumori - Struttura Complessa Di Cardiologia Milano MI
Italy Ospedale Civile - U.O. Cardiologia Mirano VE
Italy Ospedale Regina Montis Regalis - U.O. Cardiologia-Utic Mondovì CN
Italy Fondazione Pascale - S.C. Cardiologia Napoli
Italy Ospedale San Gennaro - U.O. Cardiologia E Riabilitazione Card. Napoli
Italy Ospedale Sacro Cuore - U.O. Di Cardiologia Negrar VR
Italy Aou Maggiore Della Carita' - Cardiologia Ii Novara
Italy Ospedale San Francesco - Cardiologia - Utic Nuoro NU
Italy Ospedale San Luigi Gonzaga - S.C.D.O. Cardiologia Orbassano TO
Italy Istituto Oncologico Veneto - Cardiologia Oncologica Padova PD
Italy Aor Villa Sofia-Cervello P.O. Cervello, Uo Cardiologia - Cervello Palermo PA
Italy Ospedale Spoke Paola- Cetraro Po Paola - Utic Cardiologia Paola CS
Italy Fondazione Irccs Policlinico San Matteo - Cardiologia Pavia PV
Italy Ics Maugeri Spa Societa' Benefit - U.O. Di Riabilitazione Cardiologica Pavia PV
Italy Presidio Ospedaliero San Salvatore - Cardiologia E Utic Pesaro PU
Italy Ospedale Civile Dello Spirito Santo - Utic E Cardiologia Interventistica Pescara PE
Italy Ospedale Ss. Cosma E Damiano - U. O. Cardiologia - Utic Pescia
Italy Ospedale Civile E. Agnelli - Sc Di Cardiologia Pinerolo TO
Italy Azienda Ospedaliera Universitaria Pisana - U.O. Malattie Cardiovasc. I - Cisanello Pisa PI
Italy Ospedale Dell'Alta Val D'Elsa - Uosd Cardiologia-Utic Poggibonsi SI
Italy Ospedale Santa Maria Degli Ungheresi - Uoc Cardiologia-Utic Polistena RC
Italy Ospedale Santa Maria Delle Grazie - U.O. Cardiologia - Utic Pozzuoli
Italy Ospedale Giovanni Paolo Ii - U.O.C. Cardiologia-Utic Ragusa RG
Italy Ospedale Civile Santa Maria Delle Croci - U.O. Di Cardiologia Ravenna RA
Italy Grande Ospedale Metropolitano-Bianchi Melacrino Morelli - Divisione Di Cardiologia Reggio Calabria RC
Italy Arcispedale Santa Maria Nuova - S.C. Cardiologia Reggio Emilia RE
Italy Ospedale G. Ceccarini - Cardiologia-Utic Riccione RN
Italy Ospedale Degli Infermi, Sc Cardiologia Rivoli TO
Italy Campus Biomedico - Cardiologia Roma RM
Italy Ifo- Istituto Naz. Tumori Regina Elena - Uo Cardiologia Roma RM
Italy Ospedale San Camillo - Uosd Servizi Cardiologici Integrati Roma RM
Italy Ospedale Sandro Pertini, Uoc Cardiologia Roma
Italy P.O. San Filippo Neri - Asl Roma 1 - Uoc Cardiologia E Utic Roma RM
Italy Policlinico Agostino Gemelli - Uo Cardiologia Per Sc E Riab. Cardiolog. Roma RM
Italy Ospedale Santa Maria Del Carmine - Cardiologia Rovereto TN
Italy Aou S. Giovanni Di Dio-Ruggi D'Aragona - Cardiologia Intensiva Salerno SA
Italy Ospedale San Giuseppe E Melorio - U.O.C. Cardiologia Utic Santa Maria Capua Vetere CE
Italy Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia Saronno VA
Italy Ospedale San Bartolomeo - U.O. Cardiologia Clinica-Riabilitativa Sarzana SP
Italy Ospedale Di Sassuolo - Cardiologia Sassuolo MO
Italy Ospedale Maggiore Ss. Annunziata - Sc Cardiologia Savigliano CN
Italy Ospedale Ignazio Veris Delli Ponti - Uoc Cardiologia-Utic Scorrano LE
Italy Ospedale Civile G. Mazzini - Cardiologia Utic Ed Emodinamica Teramo TE
Italy Azienda Ospedaliera Santa Maria - S.C. Di Cardiologia Terni TR
Italy Aou Citta' Della Salute E Della Scienza - S.C.D.U. Cardiologia Torino TO
Italy Ospedale Giovanni Bosco - Sc Cardiologia Torino TO
Italy Ospedale Humanitas Gradenigo - Cardiologia Torino TO
Italy Ospedale Mauriziano Umberto I - Sc Cardiologia Torino TO
Italy Ospedali Treviglio-Caravaggio - Cardiologia Treviglio BG
Italy Asui Trieste - S.C. Centro Cardiovascolare Trieste TS
Italy Pou Santa Maria Della Misericordia - S.O.C. Cardiologia Udine UD
Italy Ospedale Di Vizzolo Predabissi - Uo Cardiologia E Ucc Vizzolo Predabissi MI
Netherlands Rijnstate Ziekenhuis - Afdeling Cardioresearch Arnhem
Netherlands Tergooi - Poli cardiologie / poli 2 Blaricum
Netherlands Amphia Ziekenhuis - Research Cardiologie Breda
Netherlands Jeroen Bosch Ziekenhuis - Research Cardiologie Den Bosch
Netherlands Martini Ziekenhuis - Dept. Cardio Research Noord BV Groningen
Netherlands Diakonessenhuis - Research Cardiologie Utrecht
Netherlands University Medical Center Utrecht - Cardiologie Utrecht
Netherlands Máxima Medisch Centrum - Poli Cardiologie Veldhoven
Portugal Prof. Doutor Fernando Fonseca EPE Hospital, Cardiologia Amadora
Portugal Hospital Nossa Senhora do Rosário, Cardiology Barreiro
Portugal Hospital da Luz Lisboa
Portugal Hospital de Santa Cruz, Cardiology Lisboa
Portugal Hospital Santa Maria, Cardiology Lisboa
Spain Hospital del Mar (Parc de Salut Mar),Cardiologa I Unitat Coronaria Barcelona
Spain Hospital Médico-Quirúrgico, Cardiology Jaén
Spain Clínica Anderson, Oncología Médica Madrid
Spain Clínica Medicentro, Cardiología Madrid
Spain Hopsital Puerta de Hierro Madrid
Spain Hospital La Moraleja, Servicio de Cardiología Madrid
Spain Hospital La Paz Madrid
Spain Hospital La Zarzuela Madrid
Spain Hospital Montepríncipe, Cardiología Madrid
Spain Hospital Ramón y Cajal Madrid
Spain Hospital Rúber Internacional, Oncología Madrid
Spain Hospital Universitario Gregorio Marañón, Servicio de Cardiología Madrid
Spain Hospital Virgen de Arrixaca - Cardiologia Murcia
Spain Hospital de Salamanca, Cardiología Salamanca
Spain Hospital Universitario Virgen Macarena, Cardiologia Sevilla
Spain Hospital de Torrejón Torrejón De Ardoz
Spain Hospital Universitario Río Hortega, Cardiología Valladolid
Spain University Clinical Hosp. de Valladolid, Cardiología Valladolid
Spain Hospital Clínico "Lozano Blesa", Cardiologia Zaragoza

Sponsors (1)

Lead Sponsor Collaborator
Heart Care Foundation

Countries where clinical trial is conducted

Belgium,  Ireland,  Italy,  Netherlands,  Portugal,  Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patients with AF and cancer treated with oral anticoagulant therapy and with other antithrombotic therapy Number of patients with AF and cancer treated with oral anticoagulant therapy and with other antithrombotic therapy Baseline
Primary Patients with AF and cancer treated with oral anticoagulant therapy and with other antithrombotic therapy Number of patients with AF and cancer treated with oral anticoagulant therapy and with other antithrombotic therapy 12 Months
Secondary Patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing all cause stroke Number of patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing all cause stroke Baseline and 12 months
Secondary Patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing transient ischemic attacks Number of patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing transient ischemic attacks Baseline and 12 months
Secondary Patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing major adverse cardiovascular events (non fatal MI, non fatal stroke, non fatal systemic embolic events, cardiovascular death) Number of patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing major adverse cardiovascular events (non fatal MI, non fatal stroke, non fatal systemic embolic events, cardiovascular death) Baseline and 12 months
Secondary Patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing systemic embolic events Number of patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing systemic embolic events Baseline and 12 months
Secondary Patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing acute coronary syndrome Number of patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing acute coronary syndrome Baseline and 12 months
Secondary Patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing venous thromboembolic events, defined as composite of deep vein thrombosis and pulmonary embolism Number of patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing venous thromboembolic events, defined as composite of deep vein thrombosis and pulmonary embolism Baseline and 12 months
Secondary Patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing deep vein thrombosis Number of patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing deep vein thrombosis Baseline and 12 months
Secondary Patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing pulmonary embolism Number of patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing pulmonary embolism Baseline and 12 months
Secondary Patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing major bleeding (Fatal bleeding, Non-fatal bleeding,Intracranial hemorrhage Number of patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing major bleeding (Fatal bleeding, Non-fatal bleeding,Intracranial hemorrhage Baseline and 12 months
Secondary Patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing clinically relevant non-major bleeding Number of patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing clinically relevant non-major bleeding Baseline and 12 months
Secondary Patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing composite of major and CRNM bleeding Number of patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing composite of major and CRNM bleeding Baseline and 12 months
Secondary Patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing all-cause death Number of patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing all-cause death Baseline and 12 months
Secondary Patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing cardiovascular death Number of patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing cardiovascular death Baseline and 12 months
Secondary Patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing death due to malignancy Number of patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing death due to malignancy Baseline and 12 months
Secondary Patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing sudden and unexplained death Number of patients treated with oral anticoagulant therapy, other antithrombotic therapy or not treated experiencing sudden and unexplained death Baseline and 12 months
Secondary Association of various antithrombotic treatments (or lack of) on hospital admissions due to CV or non CV causes Number of hospital admissions (defined as = 24 h stay in a hospital) due to CV or non CV causes Baseline and 12 months
Secondary Association of various antithrombotic treatments (or lack of) on hospital admissions due to CV or non CV causes Length of hospital admissions (defined as = 24 h stay in a hospital) due to CV or non CV causes; Baseline and 12 months
Secondary Treatment satisfaction Treatment satisfaction as assessed by the Perception Anticoagulant Treatment Questionnaire (PACT-Q) Baseline and 12 months
Secondary Quality of life satisfaction Health related quality of life as assessed by the EuroQol (EQ-5D-5L) questionnaire Baseline and 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients